Abstract
Recent reports have documented substantial proportions of asymptomatic or mildly symptomatic Covid-19 infections that may also be infectious [1-3] as well as the potential role of respiratory droplets and contaminated surfaces in driving SARS-CoV-2 transmission [4]. While facemask use is promoted in healthcare settings as part of infection control protocols [5-8], its use during the COVID-19 pandemic varies across countries [9,10]. As the COVID-19 pandemic rages on, widespread facemask use has been recently recommended by Dr. George Gao, the director-general of the Chinese Center for Disease Control and Prevention (CDC) [11].
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
none
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is included in the appendix
